Efficacy and Safety of Tislelizumab Combined With Bevacizumab and Albumin Paclitaxel in Lung Adenocarcinoma

NCT04310943 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Lung Adenocarcinoma Stage IV

Interventions

DRUG: Tislelizumab

Sponsor

Zhou Chengzhi